Burleson & Company, LLC Adma Biologics, Inc. Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
A detailed history of Burleson & Company, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Burleson & Company, LLC holds 12,407 shares of ADMA stock, worth $224,442. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,407
Previous 12,407
-0.0%
Holding current value
$224,442
Previous $30,000
60.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$337 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$263 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$238 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$161 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$146 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.55B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...